Clinical Trials Browser

Adenocarcinoma of the Pancreas × durvalumab × Gastrointestinal × Clear all

NCT03490760 2023-10-12

Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas

Phase 2 Terminated

9 enrolled 12 charts

Gastrointestinal

Adenocarcinoma of the Pancreas